Intraventricular Trigone Pleomorphic Xanthoastrocytoma: A Rare Presentation with Favorable Prognosis in a Young Adult—A Case Report

Abstract

Pleomorphic xanthoastrocytoma (PXA) is a rare, Grade II astrocytic tumor typically found in the temporal lobe and often presents with seizures. We report a unique case of intraventricular trigone PXA, a rare location that mimicked an intraventricular meningioma on imaging. A 26-year-old male presented with progressive visual loss, and magnetic resonance imaging revealed a well-defined lesion in the right lateral ventricle. The patient underwent subtotal tumor resection, followed by adjuvant radiotherapy. Histopathological analysis confirmed PXA with BRAF V600E mutation, and subsequent imaging showed successful tumor control with no recurrence after 2 years. This case highlights the importance of differentiating PXA from other neoplasms, such as meningiomas, and demonstrates the favorable prognosis of PXA when appropriately managed.

Keywords

pleomorphic xanthoastrocytoma - intraventricular trigone - gliomas

Publikationsverlauf

Artikel online veröffentlicht:
01. Mai 2025

• References

• 1 Giannini C, Scheithauer BW, Burger PC. et al. Pleomorphic xanthoastrocytoma: what do we really know about it?. Cancer 1999; 85 (09) 2033-2045
• 2 Louis DN, Perry A, Reifenberger G. et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 2016; 131 (06) 803-820
• 3 Mahajan S, Dandapath I, Garg A, Sharma MC, Suri V, Sarkar C. The evolution of pleomorphic xanthoastrocytoma: from genesis to molecular alterations and mimics. Lab Invest 2022; 102 (07) 670-681
• 4 Tan D, Lai LT, Daly CD, Tran V, Maingard J, Timms C. Spinal pleomorphic xanthoastrocytoma: case report and literature review. World Neurosurg 2020; 141: 25-32
• 5 Telemi E, Martirosyan NL, , J Avila M, Lukefahr AL, Le C, Lemole GM. Suprasellar pleomorphic xanthoastrocytoma: a case report. Surg Neurol Int 2019; 10: 72
• 6 Hanna JA, Mathkour M, Gouveia EE. et al. Pleomorphic xanthoastrocytoma of the pineal region in a pediatric patient with neurofibromatosis type 1. Ochsner J 2020; 20 (02) 226-231
• 7 Kim SH, Hwang K, Lee KS, Choe G, Kim CY. Cerebellar pleomorphic xanthoastrocytoma with BRAF V600E mutation. World Neurosurg 2020; 139: 577-581
• 8 Pierallini A, Bonamini M, Di Stefano D, Siciliano P, Bozzao L. Pleomorphic xanthoastrocytoma with CT and MRI appearance of meningioma. Neuroradiology 1999; 41 (01) 30-34
• 9 Korshunov A, Golanov A. Pleomorphic xanthoastrocytomas: immunohistochemistry, grading and clinico-pathologic correlations. An analysis of 34 cases from a single Institute. J Neurooncol 2001; 52 (01) 63-72
• 10 Ferrer M, Kahl S, Nallino B. et al. PATH-55. Unraveling the complexities of recurrent pleomorphic xanthoastrocytoma: insights from aberrant immunohistochemistry and BRAF V600E mutation. Neuro-oncol 2023; 25 (Suppl. 05) v181
• 11 Dias-Santagata D, Lam Q, Vernovsky K. et al. BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications. PLoS One 2011; 6 (03) e17948
• 12 Ono T, Sasajima T, Shimizu H. et al; Tohoku Brain Tumor Study Group. Molecular features and prognostic factors of pleomorphic xanthoastrocytoma: a collaborative investigation of the Tohoku Brain Tumor Study Group. Neurol Med Chir (Tokyo) 2020; 60 (11) 543-552
• 13 Lou L, Li J, Qin M, Tian X, Guo W, Li Y. Correlation of MTAP immunohistochemical deficiency with CDKN2A homozygous deletion and clinicopathological features in pleomorphic xanthoastrocytoma. Brain Tumor Pathol 2023; 40 (01) 15-25
• 14 Vaubel R, Zschernack V, Tran QT. et al. Biology and grading of pleomorphic xanthoastrocytoma-what have we learned about it?. Brain Pathol 2021; 31 (01) 20-32